TrulanceImmediate release (Synergy Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Trulance drug offered from Synergy Pharmaceuticals Inc.. This Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Synergy Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Plecanatide
SUBSTANCE NAME: PLECANATIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-02-21
END MARKETING DATE: 0000-00-00


Trulance Immediate release HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrulance Immediate release from Synergy Pharmaceuticals Inc.
LABELER NAME: Synergy Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3(mg/1)
START MARKETING DATE: 2017-02-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70194-003_ca278606-3ce4-4745-9879-26992a45c910
PRODUCT NDC: 70194-003
APPLICATION NUMBER: NDA208745

Other PLECANATIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Synergy Pharmaceuticals Inc.Trulance